The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction
Open Access
- 1 March 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 318 (3) , H706-H714
Abstract
Matrix metalloproteinases (MMPs) are proteolytic enzymes that break down extracellular matrix (ECM) components and have shown to be highly active in the myocardial infarction (MI) landscape. In addition to breaking down ECM products, MMPs modulate cytokine signaling and mediate leukocyte cell physiology. MMP-2, -7, -8, -9, -12, -14, and -28 are well studied as effectors of cardiac remodeling after MI. Whereas 13 MMPs have been evaluated in the MI setting, 13 MMPs have not been investigated during cardiac remodeling. Here, we measure the remaining MMPs across the MI time continuum to provide the full catalog of MMP expression in the left ventricle after MI in mice. We found that MMP-10, -11, -16, -24, -25, and -27 increase after MI, whereas MMP-15, -17, -19, -21, -23b, and -26 did not change with MI. For the MMPs increased with MI, the macrophage was the predominant cell source. This work provides targets for investigation to understand the full complement of specific MMP roles in cardiac remodeling. NEW & NOTEWORTHY To date, a number of matrix metalloproteinases (MMPs) have not been evaluated in the left ventricle after myocardial infarction (MI). This article supplies the missing knowledge to provide a complete MI MMP compendium.Keywords
Funding Information
- HHS | National Institutes of Health (HL075360, HL129823, and HL137319)
- Veterans Administration (5I01BX000505)
This publication has 49 references indexed in Scilit:
- Matrix Metalloproteinase-28 Deletion Exacerbates Cardiac Dysfunction and Rupture After Myocardial Infarction in Mice by Inhibiting M2 Macrophage ActivationCirculation Research, 2013
- MiR‐155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP‐16Journal of Cellular and Molecular Medicine, 2012
- Classical Macrophage Activation Up-Regulates Several Matrix Metalloproteinases through Mitogen Activated Protein Kinases and Nuclear Factor-κBPLOS ONE, 2012
- Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodellingJournal of Cellular and Molecular Medicine, 2011
- Tissue Inhibitor of Metalloproteinase‐2 Gene Delivery Ameliorates Postinfarction Cardiac RemodelingClinical and Translational Science, 2011
- Mice with Tissue Inhibitor of Metalloproteinases 4 (Timp4) Deletion Succumb to Induced Myocardial Infarction but Not to Cardiac Pressure OverloadJournal of Biological Chemistry, 2010
- Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarctionAmerican Heart Journal, 2006
- Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and proteinBiochemical Journal, 2003
- Catalytic activities of membrane‐type 6 matrix metalloproteinase (MMP25)FEBS Letters, 2001